Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nitto Denko Corp.
DescriptionTransdermal 12-hour insulin patch using PassPort Delivery system
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today